These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 37192823

  • 1. 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review.
    AlSadi R, Maaz AUR, Bouhali O, Djekidel M.
    J Nucl Med Technol; 2023 Jun; 51(2):140-146. PubMed ID: 37192823
    [Abstract] [Full Text] [Related]

  • 2. 68Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use.
    Maaz AUR, O'Doherty J, Djekidel M.
    J Nucl Med Technol; 2021 Sep; 49(3):265-268. PubMed ID: 33820858
    [Abstract] [Full Text] [Related]

  • 3. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
    Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, Kranewitter C, Warwitz B, Waitz D, Kendler D, Virgolini IJ.
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
    [Abstract] [Full Text] [Related]

  • 4. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
    Gains JE, Aldridge MD, Mattoli MV, Bomanji JB, Biassoni L, Shankar A, Gaze MN.
    Nucl Med Commun; 2020 Nov; 41(11):1169-1177. PubMed ID: 32796449
    [Abstract] [Full Text] [Related]

  • 5. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K, Khan S, Taghizadehasl M, Palazzo F, Frilling A, Todd JF, Al-Nahhas A.
    Hell J Nucl Med; 2015 Nov; 18(1):19-24. PubMed ID: 25679074
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
    Maurice JB, Troke R, Win Z, Ramachandran R, Al-Nahhas A, Naji M, Dhillo W, Meeran K, Goldstone AP, Martin NM, Todd JF, Palazzo F, Tan T.
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961
    [Abstract] [Full Text] [Related]

  • 7. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Etchebehere EC, de Oliveira Santos A, Gumz B, Vicente A, Hoff PG, Corradi G, Ichiki WA, de Almeida Filho JG, Cantoni S, Camargo EE, Costa FP.
    J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
    [Abstract] [Full Text] [Related]

  • 8. Performing [18F]MFBG Long-Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma.
    Borgwardt L, Brok J, Andersen KF, Madsen J, Gillings N, Fosbøl MØ, Denholt CL, Petersen IN, Sørensen LS, Enevoldsen LH, Oturai PS, Johannesen HH, Højgaard L, Schulze C, Saxtoft E, Andersen F, Fischer BM.
    J Nucl Med; 2024 Aug 01; 65(8):1286-1292. PubMed ID: 38960713
    [Abstract] [Full Text] [Related]

  • 9. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
    Deppen SA, Liu E, Blume JD, Clanton J, Shi C, Jones-Jackson LB, Lakhani V, Baum RP, Berlin J, Smith GT, Graham M, Sandler MP, Delbeke D, Walker RC.
    J Nucl Med; 2016 May 01; 57(5):708-14. PubMed ID: 26769865
    [Abstract] [Full Text] [Related]

  • 10. The Complementary Role of 68Ga-DOTATATE PET/CT in Neuroblastoma.
    Telli T, Lay Ergün E, Volkan Salanci B, Özgen Kiratli P.
    Clin Nucl Med; 2020 Apr 01; 45(4):326-329. PubMed ID: 31977455
    [Abstract] [Full Text] [Related]

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Apr 01; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 12. The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.
    Shell J, Tirosh A, Millo C, Sadowski SM, Assadipour Y, Green P, Patel D, Nilubol N, Kebebew E.
    Eur J Radiol; 2019 Mar 01; 112():130-135. PubMed ID: 30777201
    [Abstract] [Full Text] [Related]

  • 13. The utility of 68Ga-DOTATATE PET/CT in localizing primary/metastatic pheochromocytoma and paraganglioma in children and adolescents - a single-center experience.
    Jaiswal SK, Sarathi V, Malhotra G, Hira P, Shah R, Patil VA, Dalvi A, Prakash G, Lila AR, Shah NS, Bandgar T.
    J Pediatr Endocrinol Metab; 2021 Jan 27; 34(1):109-119. PubMed ID: 33180042
    [Abstract] [Full Text] [Related]

  • 14. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB.
    J Nucl Med; 2011 Apr 27; 52(4):519-25. PubMed ID: 21421719
    [Abstract] [Full Text] [Related]

  • 15. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
    Win Z, Al-Nahhas A, Towey D, Todd JF, Rubello D, Lewington V, Gishen P.
    Nucl Med Commun; 2007 May 27; 28(5):359-63. PubMed ID: 17414885
    [Abstract] [Full Text] [Related]

  • 16. Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma.
    Fathpour G, Jafari E, Hashemi A, Dadgar H, Shahriari M, Zareifar S, Jenabzade AR, Vali R, Ahmadzadehfar H, Assadi M.
    Clin Nucl Med; 2021 Jul 01; 46(7):540-548. PubMed ID: 33782280
    [Abstract] [Full Text] [Related]

  • 17. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    Crown A, Rocha FG, Raghu P, Lin B, Funk G, Alseidi A, Hubka M, Rosales J, Lee M, Kennecke H.
    J Surg Oncol; 2020 Mar 01; 121(3):480-485. PubMed ID: 31853990
    [Abstract] [Full Text] [Related]

  • 18. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM, Neychev V, Millo C, Shih J, Nilubol N, Herscovitch P, Pacak K, Marx SJ, Kebebew E.
    J Clin Oncol; 2016 Feb 20; 34(6):588-96. PubMed ID: 26712231
    [Abstract] [Full Text] [Related]

  • 19. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with 68Ga-DOTATATE and 18F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting.
    Sampathirao N, Basu S.
    J Nucl Med Technol; 2017 Mar 20; 45(1):34-41. PubMed ID: 28154019
    [Abstract] [Full Text] [Related]

  • 20. The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom.
    Skoura E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, Al Harbi M, Toumpanakis C, Almukhailed O, Kayani I, Syed R, Navalkissoor S, Ell PJ, Caplin ME, Bomanji J.
    J Nucl Med; 2016 Jan 20; 57(1):34-40. PubMed ID: 26471695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.